Tonix Pharmaceuticals Announces Acquisition of Non-Addictive Migraine and Pain Treatment Programs from Trigemina and Assumption of License

NEXT STORY
LHC Group promotes Joshua Proffitt to President and welcomes Robert Williams as new Chief Financial Officer
PREV STORY
Despite COVID-19, The Doctor is Still In
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

author_avatar
NASDAQ Market News

Evaxion Biotech Receives Regulatory Clearance to Initiate Phase 2 Trial of EVX-01 in Combination with KEYTRUDA® for Treatment of Melanoma

author_avatar
NASDAQ Market News

Richard Hill, MD, PhD, is Elected to the American Health Council’s Board of Physicians

NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- The American Health Council is honored ...

author_avatar
NASDAQ Market News